More tools:Markets·Screener·Research·Chat

AC Immune SA (ACIU) Financial Statements

AC Immune SA
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG00D0RHJ65
XNAS · usd
2.76▼ 0.02 (-0.72%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close2.78
Day's Range2.73 – 2.81
52-Week Range2.10 – 4.00
Volume146.6K
Avg Volume210.5K
Share Statistics
Shares Outstanding
Employees122
ExchangeXNAS
Listed2016-09-23
Share count as of December 31, 2025
Loading Income Statement…
Key questions about AC Immune SA (ACIU)
What is AC Immune SA's Market Cap?
AC Immune SA's Market Cap is $280.8M, based on as-reported figures from SEC (XBRL) filings.
What is AC Immune SA's Enterprise Value?
AC Immune SA's Enterprise Value is $246.5M, based on as-reported figures from SEC (XBRL) filings.
What is AC Immune SA's Price / Sales?
AC Immune SA's Price / Sales is 12.9×, based on as-reported figures from SEC (XBRL) filings.
What is AC Immune SA's EV / Revenue?
AC Immune SA's EV / Revenue is 11.4×, based on as-reported figures from SEC (XBRL) filings.
What is AC Immune SA's Revenue (TTM)?
AC Immune SA's Revenue (TTM) is $21.7M, based on as-reported figures from SEC (XBRL) filings.
What is AC Immune SA's Net Income (TTM)?
AC Immune SA's Net Income (TTM) is -$54.1M, based on as-reported figures from SEC (XBRL) filings.
What is AC Immune SA's Diluted EPS (TTM)?
AC Immune SA's Diluted EPS (TTM) is -0.53, based on as-reported figures from SEC (XBRL) filings.
What is AC Immune SA's Net Debt?
AC Immune SA's Net Debt is -$34.3M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2022
Revenue
Contract revenue
Total revenue
Operating expenses
Research & development expenses
General & administrative expenses
Other operating income/(expense), net
Total operating expenses
Operating loss
Financial income
Financial expense
Exchange differences
Finance result, net
Loss before tax
Loss for the period
Loss per share:
Basic loss per share for the period attributable to equity holders
Diluted loss per share for the period attributable to equity holders